Nature Communications (Nov 2022)
Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist
Abstract
The authors previously identified a family of viral insulin-like peptides (VILPs) with high homology to human insulin/IGF−1. Here, they report that one of these VILPs exhibits antagonist properties associated with a unique conformation of the IGF1R.